Invited Perspective: On Air Pollution, Epidemics, Pandemics, and Planetary Health Authors: Jouni JK Jaakkola Published: 2023 Viral respiratory infections constitute one of the leading causes of morbidity and mortality globally.1 Each year influenza is estimated to cause 291,243–645,832 deaths (4.0–8.8 per 100,000 person-years),2 but during pandemics the annual death toll can reach millions.3 For example, the Spanish flu pandemic of 1918–1920 infected 30%–50% of the global population and caused ∼50 million deaths.4 Influenza epidemics and pandemics have occurred for at least 2,400 y,1 with the first documented epidemic occurring in 412 BCE in Northern Greece5 and Rome.6 Today, influenza epidemics occur nearly every year somewhere in the world owing to antigenic drift, that is, the accumulation of a series of minor genetic mutations in the virus7; pandemics have occurred at 10- to 50-y intervals because of the emergence of new virus subtypes.4 Two important population-based epidemiological studies, published in the present issue of Environmental Health Perspectives, provide compelling and consistent evidence that the incidence of influenza episodes may be related to short-term exposure to ambient air pollution.8,9 Both teams considered exposures to six criteria air pollutants—fine particulate matter [PM ≤2.5μm in aerodynamic diameter (PM2.5)], coarse particulate matter [PM ≤10μm in aerodynamic diameter (PM10)], nitrogen dioxide (NO2), sulfur dioxide (SO2), carbon monoxide (CO), and ozone (O3)—over the period 2015–2019. Yu et al.8 conducted a time-series analysis based on 3,735,934 influenza cases in 82 cities of mainland China, representing roughly 5 billion person-years of follow-up. Zhang et al.9 conducted a case-crossover study including 108,479 cases in the city of Guangzhou, with 76.5 million person-years of follow-up. All pollutants except O3 were associated with an increased risk of an influenza episode in single-pollutant models. Zhang et al.9 concluded that older age, winter season, high population density, and low vegetation increased the effects of air pollution on the risk of influenza. This new evidence is based on study designs and analytical approaches that are typically used to research the effects of short-term exposure to air pollution on the risk of noncommunicable chronic diseases.10,11 In noncommunicable diseases, exposure affects only the pathophysiology of the underlying outcomes, whereas for infectious diseases air pollution may affect both the virulence of the virus and the susceptibility of the host. If air pollution indeed amplifies both virulence and host susceptibility, an increase in exposure has the potential to produce a cascade of infectious disease episodes. Applying the paradigm of chronic disease epidemiology, we can infer that a reduction in air pollution will reduce the risk of influenza episodes. Yu et al. estimated that 7.66% of the influenza cases in Guangzhou were attributable to PM2.5 exposure. However, the dynamics of infectious diseases include features that make the interpretation of these new findings more complicated and raise further questions from a different perspective. The role of air pollution in increasing influenza epidemics has been elaborated at the a) cellular (biomedicine), b) individual (clinical medicine), and c) population (public health medicine) levels. However, the experience of the COVID-19 pandemic has underlined the need for a new dimension: planetary health. At the individual level, exposure to air pollution may plausibly increase the risk of influenza in different aspects of the causal pathway. These aspects include pathogen transmission, virulence of the pathogen, pathogen pressure (i.e., the number of virus particles entering the host’s airways), host susceptibility, and manifestation of clinical disease. However, we still have fundamental knowledge gaps about the effects of air pollution on these different stages. At the population level, air pollution may affect the spread of an influenza epidemic by changing the infectiousness of the pathogen, the behavior of the population (with impacts on pathogen pressure), and host susceptibility. Exposure to air pollution is likely to alter immune responses12 and host immunity to respiratory infections,13 which may then facilitate the spread of the epidemic. High levels of air pollution may also encourage people to increase the time spent indoors at home or in public spaces, multiplying the number of human contacts and leading to an increase in pathogen pressure. The immunological status of the population due to vaccination or previously experienced influenza episodes may have a critical impact on the effect of air pollution exposure on the risk of influenza. Thus, the impact of air pollution on influenza risk may be reduced by the development of population-level immunity. During the 2015–2019 study period, the coverage of influenza vaccination in China was generally low (<10%).14 At the planetary level, combustion of fossil fuels may increase the occurrence of influenza by increasing both short- and long-term exposures to air pollutants. It may also act indirectly by contributing to climate change. In a recent review, He et al.15 summarized evidence showing that climate change may increase the risk of viral respiratory infections and their transmission by altering viral biology, host susceptibility, human behavior, and environmental conditions of both society and ecosystems. Climate change is also an important driver for extensive global land use change, leading to anthropogenically induced ecosystem disruption that is likely to induce zoonotic pathogen spillover from wildlife to human populations.16 This could increase the emergence of new types of influenza viruses and other infectious pathogens with the potential to cause future epidemics and pandemics. From the planetary health perspective, climate change increases the risk of viral respiratory infection emergence and transmission in several ways.15,16 Therefor, transitioning from fossil fuel–based energy—a major driver of climate change—to clean sources of energy is an important and urgent measure for preventing future epidemics and pandemics of influenza or COVID-19, as well as other infections and noninfectious diseases. Refers to https://doi.org/10.1289/EHP12145 and https://doi.org/10.1289/EHP12146 References